The approval comes amidst rumours of a potential private equity buyout of the Canadian company, whose parent company has ...

Shares in Bausch + Lomb were higher after the company received approval from the Food and Drug Administration for its enVista Envy full range of vision intraocular lens. Shares were recently up 23% at ...

Bausch + Lomb receives US FDA approval for enVista Envy full range of vision intraocular lens: Vaughan, Ontario Tuesday, October 15, 2024, 17:00 Hrs [IST] Bausch + Lomb Corporatio ...

According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks ...

What are the signs that show I need cataract surgery? "There are several key signs that someone may need cataract surgery," ...

A special needs child from HD Kote Taluk underwent successful bilateral cataract surgery, restoring sight and hope, thanks to ...

The FDA granted approval to the enVista Envy full range of vision IOLs following Canadian approval in May 2024.

Its growth is attributed to a trend towards medical tourism for low-cost procedures. The global ophthalmology devices market ...

The fifth annual Optegra Eye Sciences & Zeiss symposium, entitled Hands-on with latest innovations in ophthalmology, took ...

Bausch + Lomb Corp. (BLCO, BLCO.TO) announced that the U.S. Food and Drug Administration has approved the enVista Envy full range of ...

Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2024. "Johnson & Johnson’s strong results in the third quarter reflect the unique breadth of our business and commitment to ...